Published in AIDS Weekly, October 30th, 2006
According to a recent report from the United States, "This study examined the relationship between HIV serostatus disclosure and adherence to antiretroviral therapy (ART).
"The study was conducted with 215 HIV-seropositive patients who demonstrated poor adherence (<80%) and who were in serodiscordant relationships. Participants completed self-report measures regarding HIV serostatus disclosure and reasons for missing ART doses, as well as electronic monitoring of ART adherence (MEMS caps)."
"Overall," reported investigators, "19% of the sample...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.